0.9696
price down icon1.06%   -0.0104
after-market Handel nachbörslich: 2.58 1.6104 +166.09%
loading
Schlusskurs vom Vortag:
$0.98
Offen:
$0.99
24-Stunden-Volumen:
77,948
Relative Volume:
0.89
Marktkapitalisierung:
$6.59M
Einnahmen:
-
Nettoeinkommen (Verlust:
$22.68M
KGV:
1.8294
EPS:
0.53
Netto-Cashflow:
$-1.94M
1W Leistung:
+1.51%
1M Leistung:
+3.26%
6M Leistung:
-22.43%
1J Leistung:
-49.24%
1-Tages-Spanne:
Value
$0.9408
$0.99
1-Wochen-Bereich:
Value
$0.906
$1.18
52-Wochen-Spanne:
Value
$0.80
$2.4229

Pharmacyte Biotech Inc Stock (PMCB) Company Profile

Name
Firmenname
Pharmacyte Biotech Inc
Name
Telefon
(917) 595.2850
Name
Adresse
3960 HOWARD HUGHES PARKWAY, LAS VEGAS
Name
Mitarbeiter
2
Name
Twitter
Name
Nächster Verdiensttermin
2025-09-30
Name
Neueste SEC-Einreichungen
Name
PMCB's Discussions on Twitter

Vergleichen Sie PMCB mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
2.24 0 0 0 0 0.00
 icon
MOBBW
Mobilicom Limited Warrants
4.34 6.18B 0 0 0 0.00
 icon
GOODO
Gladstone Commercial Corporation
20.12 372.90M 0 0 0 0.00
 icon
SHMD
Schmid Group N V
2.825 133.49M 0 0 0 0.00
 icon
PSNYW
Polestar Automotive Holding Uk
0.2646 577.51M 2.07B -1.42B -1.37B -0.6765
 icon
DAVEW
Dave Inc
1.085 0 0 0 0 0.00

Pharmacyte Biotech Inc Aktie (PMCB) Neueste Nachrichten

pulisher
Sep 30, 2025

Regression analysis insights on PharmaCyte Biotech Inc. performance2025 Year in Review & Real-Time Stock Price Movement Reports - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Intraday pattern recognizer results for PharmaCyte Biotech Inc.Trade Performance Summary & Stepwise Entry/Exit Trade Alerts - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Is PharmaCyte Biotech Inc. stock bottoming outOptions Play & Community Consensus Picks - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Will PharmaCyte Biotech Inc. stock return to pre crisis levels2025 Key Lessons & Breakout Confirmation Alerts - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Relative strength of PharmaCyte Biotech Inc. in sector analysisGap Up & Smart Investment Allocation Insights - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

PharmaCyte Biotech Inc. stock prediction for this weekJuly 2025 Patterns & AI Powered Market Entry Strategies - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

PharmaCyte Biotech Inc. recovery potential after sell off2025 Investor Takeaways & Weekly Chart Analysis and Guides - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

Will PharmaCyte Biotech Inc. stock benefit from sector rotationJuly 2025 Spike Watch & Long-Term Safe Return Strategies - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Smart tools for monitoring PharmaCyte Biotech Inc.’s price actionJuly 2025 Reactions & High Accuracy Trade Signal Alerts - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

What drives PharmaCyte Biotech Inc stock priceInstitutional Buying Trends & AI-Driven Stock Forecast Models - earlytimes.in

Sep 29, 2025
pulisher
Sep 22, 2025

Published on: 2025-09-24 11:34:11 - newser.com

Sep 22, 2025
pulisher
Sep 22, 2025

Published on: 2025-09-22 08:22:22 - newser.com

Sep 22, 2025
pulisher
Sep 21, 2025

How to escape a deep drawdown in PharmaCyte Biotech Inc.Market Growth Review & Weekly Market Pulse Alerts - newser.com

Sep 21, 2025
pulisher
Sep 20, 2025

Sentiment analysis tools applied to PharmaCyte Biotech Inc.2025 Institutional Moves & Fast Exit Strategy with Risk Control - newser.com

Sep 20, 2025
pulisher
Sep 20, 2025

FOMO Trade: Should you buy the dip on PharmaCyte Biotech Inc2025 Price Action Summary & Fast Gain Swing Alerts - خودرو بانک

Sep 20, 2025
pulisher
Sep 19, 2025

Earnings visualization tools for PharmaCyte Biotech Inc.Quarterly Portfolio Summary & Community Verified Watchlist Alerts - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Measuring PharmaCyte Biotech Inc.’s beta against major indicesWeekly Stock Report & AI Forecasted Entry/Exit Points - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

How to build a custom watchlist for PharmaCyte Biotech Inc.M&A Rumor & Risk Managed Investment Entry Signals - newser.com

Sep 19, 2025

Finanzdaten der Pharmacyte Biotech Inc-Aktie (PMCB)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.66
price down icon 2.36%
$84.81
price up icon 1.10%
$30.67
price up icon 4.57%
$98.62
price up icon 0.53%
$144.01
price up icon 1.67%
biotechnology ONC
$340.70
price up icon 2.36%
Kapitalisierung:     |  Volumen (24h):